State Street’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-374,531
| Closed | -$2.08M | – | 4365 |
|
|
2024
Q2 | $2.08M | Buy |
374,531
+241,515
| +182% | +$858K | ﹤0.01% | 3306 |
|
|
2024
Q1 | $519K | Buy |
+133,016
| New | +$506K | ﹤0.01% | 3638 |
|
|
2016
Q4 | – | Sell |
-1,525
| Closed | -$34K | – | 3691 |
|
|
2016
Q3 | $34K | Hold |
1,525
| – | – | ﹤0.01% | 3506 |
|
|
2016
Q2 | $28K | Sell |
1,525
-22,487
| -94% | -$598K | ﹤0.01% | 3637 |
|
|
2016
Q1 | $630K | Buy |
24,012
+3,148
| +15% | +$98K | ﹤0.01% | 3308 |
|
|
2015
Q4 | $757K | Sell |
20,864
-867
| -4% | -$37.6K | ﹤0.01% | 3270 |
|
|
2015
Q3 | $719K | Buy |
21,731
+1,417
| +7% | +$79.8K | ﹤0.01% | 3269 |
|
|
2015
Q2 | $1.4M | Buy |
20,314
+42
| +0.2% | +$2.9K | ﹤0.01% | 3172 |
|
|
2015
Q1 | $1.53M | Buy |
20,272
+2,687
| +15% | +$211K | ﹤0.01% | 3118 |
|
|
2014
Q4 | $1.46M | Buy |
17,585
+871
| +5% | +$70.7K | ﹤0.01% | 3156 |
|
|
2014
Q3 | $1.36M | Buy |
16,714
+549
| +3% | +$46.9K | ﹤0.01% | 3164 |
|
|
2014
Q2 | $1.45M | Buy |
16,165
+1,273
| +9% | +$113K | ﹤0.01% | 3161 |
|
|
2014
Q1 | $1.76M | Buy |
14,892
+4,677
| +46% | +$454K | ﹤0.01% | 3114 |
|
|
2013
Q4 | $722K | Sell |
10,215
-4
| -0% | -$163 | ﹤0.01% | 3301 |
|
|
2013
Q3 | $576K | Buy |
10,219
+8,114
| +385% | +$509K | ﹤0.01% | 3330 |
|
|
2013
Q2 | $154K | Buy |
+2,105
| New | +$122K | ﹤0.01% | 3360 |
|
State Street's ALIM Position: Q3 2024 in Review
State Street sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 374,531 shares — an estimated $2.08M sold.
State Street first reported a position in ALIM in Q2 2013 and held it in 16 quarters. The position peaked at $2.08M in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- State Street reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- State Street sold 374,531 Alimera Sciences shares in Q3 2024, an estimated $2.08M.
- State Street first reported a position in Alimera Sciences in Q2 2013 and held it in 16 quarters.
- State Street's Alimera Sciences position peaked at $2.08M in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.